Skip to main content
. 2022 Aug 18;9:945352. doi: 10.3389/fmed.2022.945352

FIGURE 1.

FIGURE 1

The decisions made when developing a pharmacogenetic program. Using pharmacogenetics in clinical practice is a complex healthcare intervention and is made up of many components (16, 80). This schematic presents some of the key design decisions made by organizations when developing a pharmacogenetic service. PDF, Portable Document Format. EHR, Electronic Health Record. SNP, Single Nucleotide Polymorphisms.